Payer Policies and Consumerism Fuel Outpatient Imaging Shift
Industry analysis suggests that payer reimbursement strategies, such as site-neutral payments, are aggressively driving imaging procedures out of hospitals and into ambulatory settings. This shift is compounded by a "consumerization" of healthcare, with patients prioritizing convenience and transparent pricing, forcing providers to modernize their patient engagement models or risk losing market share.
- Medicare payment policies that reimburse procedures at lower rates in ambulatory surgery centers (ASCs) compared to hospital outpatient departments (HOPDs) are a primary driver of the shift in care. For the same procedures, Medicare has been shown to pay ASCs about 53% of the rate paid to HOPDs, creating significant cost-saving incentives for payers and patients. - The trend of practice consolidation is reshaping the competitive landscape; from 2014 to 2023, the number of radiology-only practices decreased by 31.8%, while the number of radiologists affiliated with larger, multispecialty practices grew. During the same period, the number of practices with 100 or more radiologists increased by nearly 350%, enhancing their negotiating power with payers. - In response to these market pressures, health systems are actively developing their own freestanding imaging strategies. For example, US Radiology Specialists is on track to open 12 new outpatient centers in 2025, some in joint ventures with health systems, bringing their total to over 180 centers. Similarly, Monument Health and Dakota Radiology are jointly expanding a facility to add a new MRI and a PET/CT scanner. - The mobile medical imaging services market is projected to grow from $16.63 billion in 2025 to $21.13 billion by 2031. This growth is fueled by the decentralization of care and technological advancements, with MRI services holding the largest market share (36.35%) in 2025. - Persistent workforce shortages for radiologists and technologists create operational challenges and opportunities for service providers. In 2024, computed tomography and magnetic resonance imaging had technologist vacancy rates of 19.4% and 17.4%, respectively. This staffing gap is driving the adoption of teleradiology and other flexible staffing models to manage increasing imaging volumes. - The FDA is rapidly approving AI-powered tools for radiology, which are transforming workflows and diagnostics. By the end of 2025, the total number of FDA-approved AI/ML tools for clinical imaging is expected to surpass 1,000, with leading vendors including GE Healthcare, Siemens Healthineers, and Philips.
